Union City, CA, United States of America

Mufa Zou

USPTO Granted Patents = 3 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mufa Zou: Innovator in Oligonucleotide Drug Delivery

Introduction

Mufa Zou is a prominent inventor based in Union City, CA, known for his contributions to the field of biotechnology. He holds three patents that focus on innovative methods and compounds for drug delivery systems, particularly in the realm of oligonucleotide therapeutics.

Latest Patents

Mufa Zou's latest patents include "Lipid-pegylated compounds, preparations and uses thereof," which relates to lipid-PEGylated solid support and phosphoramidite derivatives. This patent outlines methods for preparing these compounds and their applications in delivering oligonucleotide drugs to cellular targets. Another significant patent is "Functionalized n-acetylgalactosamine analogs," which discusses the creation of functionalized N-acetylgalactosamine-analogs. This patent details methods of making these analogs and their uses, particularly in the targeted delivery of oligonucleotide-based therapeutics.

Career Highlights

Mufa Zou is associated with Hongene Biotech Corporation, where he applies his expertise in biotechnology to advance drug delivery systems. His work has significantly impacted the development of targeted therapies, enhancing the efficacy of treatments for various diseases.

Collaborations

Mufa Zou collaborates with notable colleagues, including Wing C Poon and Gang Zhao, who contribute to his research and development efforts in the field of biotechnology.

Conclusion

Mufa Zou's innovative work in oligonucleotide drug delivery exemplifies the importance of biotechnology in modern medicine. His patents reflect a commitment to advancing therapeutic techniques that can lead to more effective treatments for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…